Sobr Safe (SOBR) had the highest return between January 19, 2018 and January 24, 2018 by a US stock, returning 205.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Sobr Safe (SOBR) | 1/19/2018 - 1/24/2018 | 205.08% |
Fubotv (FUBO) | 1/19/2018 - 1/24/2018 | 183.33% |
Skye Bioscience, Inc Common Stock (SKYE) | 1/19/2018 - 1/24/2018 | 76.74% |
ProMIS Neurosciences (PMN) | 1/19/2018 - 1/24/2018 | 70% |
NuCana (NCNA) | 1/19/2018 - 1/24/2018 | 67.5% |
Addentax (ATXG) | 1/19/2018 - 1/24/2018 | 50.09% |
Applied Digital (APLD) | 1/19/2018 - 1/24/2018 | 48.33% |
Lightbridge (LTBR) | 1/19/2018 - 1/24/2018 | 42.38% |
VistaGen Therapeutics (VTGN) | 1/19/2018 - 1/24/2018 | 41.8% |
Worksport (WKSP) | 1/19/2018 - 1/24/2018 | 40.71% |
vTv Therapeutics (VTVT) | 1/19/2018 - 1/24/2018 | 35.73% |
Achieve Life Sciences (ACHV) | 1/19/2018 - 1/24/2018 | 34.67% |
Meridian (MRDN) | 1/19/2018 - 1/24/2018 | 33.33% |
Rocket Pharmaceuticals (RCKT) | 1/19/2018 - 1/24/2018 | 31.95% |
RF Industries (RFIL) | 1/19/2018 - 1/24/2018 | 30.77% |
BeyondSpring (BYSI) | 1/19/2018 - 1/24/2018 | 30.52% |
Volitionrx (VNRX) | 1/19/2018 - 1/24/2018 | 28.66% |
Educational Development (EDUC) | 1/19/2018 - 1/24/2018 | 27.94% |
Gyre Therapeutics (GYRE) | 1/19/2018 - 1/24/2018 | 27.63% |
Myomo (MYO) | 1/19/2018 - 1/24/2018 | 27.2% |
Tvardi Therapeutics (TVRD) | 1/19/2018 - 1/24/2018 | 26.22% |
FingerMotion (FNGR) | 1/19/2018 - 1/24/2018 | 25.27% |
Enlivex Therapeutics (ENLV) | 1/19/2018 - 1/24/2018 | 24.5% |
Crispr Therapeutics (CRSP) | 1/19/2018 - 1/24/2018 | 24.37% |
Ultragenyx (RARE) | 1/19/2018 - 1/24/2018 | 24.33% |